KR100813297B1 - A cosmetic composition for preventing human skin wrinkle by ultraviolet radiation - Google Patents

A cosmetic composition for preventing human skin wrinkle by ultraviolet radiation Download PDF

Info

Publication number
KR100813297B1
KR100813297B1 KR1020060064092A KR20060064092A KR100813297B1 KR 100813297 B1 KR100813297 B1 KR 100813297B1 KR 1020060064092 A KR1020060064092 A KR 1020060064092A KR 20060064092 A KR20060064092 A KR 20060064092A KR 100813297 B1 KR100813297 B1 KR 100813297B1
Authority
KR
South Korea
Prior art keywords
skin
extract
elastin
cells
human skin
Prior art date
Application number
KR1020060064092A
Other languages
Korean (ko)
Other versions
KR20080005019A (en
Inventor
박원봉
성광수
윤형영
Original Assignee
박원봉
성광수
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 박원봉, 성광수 filed Critical 박원봉
Priority to KR1020060064092A priority Critical patent/KR100813297B1/en
Publication of KR20080005019A publication Critical patent/KR20080005019A/en
Application granted granted Critical
Publication of KR100813297B1 publication Critical patent/KR100813297B1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/25Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Dermatology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cosmetics (AREA)

Abstract

본 발명은 흰털오가피 추출물의 항산화 효과 및 자외선에 의해 유발되는 피부 진피 내 구성물인 콜라겐과 엘라스틴 분해효소 억제 효과 및 엘라스틴 생성 효과 등 다양한 생리활성과 인체 피부세포의 보호 효과를 지닌 기능성 화장품 소재를 제공하는 것이다.The present invention provides a functional cosmetic material having a variety of physiological activities and protective effects of human skin cells, such as the antioxidant effect and the anti-aging effect of collagen and elastin degrading enzymes and elastin-generating effect of the skin dermis induced by UV light extract will be.

흰털오가피, 피부주름 방지, 피부노화억제, 활성산소, 인체 피부세포, 엘라스타아제, 엘라스틴, 화장품 조성물 White hair, skin wrinkle prevention, skin aging inhibitor, free radicals, human skin cells, elastase, elastin, cosmetic composition

Description

자외선에 의한 인체 피부주름 방지용 기능성 화장품 조성물{A cosmetic composition for preventing human skin wrinkle by ultraviolet radiation}A cosmetic composition for preventing human skin wrinkles by ultraviolet radiation

도 1은 48시간 동안 자외선 조사 후의 피부세포의 생존율(%)을 나타낸 그래프이다.1 is a graph showing the survival rate (%) of skin cells after UV irradiation for 48 hours.

도 2는 48시간 동안 자외선 조사 후의 피부세포 내의 엘라스틴 생성율(%)을 나타낸 그래프이다.Figure 2 is a graph showing the elastin production rate (%) in the skin cells after UV irradiation for 48 hours.

본 발명은 잎, 줄기, 뿌리 등 흰털오가피(Acanthopanax divaricatus var . albeofructus)의 물 또는 에탄올 추출물의 피부노화 억제 효과를 이용하여 피부의 자외선 노출로 인한 광노화 현상을 억제하는 인체 피부주름 방지용 기능성 화장품의 조성물에 관한 것이다.The present invention leaves, stems, roots, etc. Acanthopanax divaricatus var . albeofructus ) relates to the composition of the functional cosmetics for preventing human skin wrinkles by using the anti-aging effect of the skin or ethanol extract of the skin.

피부의 노화에 따른 표피(epidermis), 진피층(dermis) 및 피하층(subcutaneous)이 감소되는데, 그 중 진피증의 변화가 가장 현저하며 이로 인해 주름이 형성된다. 피부 진피 내 엑스트라셀룰라 매트릭스(extracellular matrix)는 피부 구조와 탄력을 유지하는 가장 중요한 역할을 하는데, 이 중진피 내 성유상으로 존재하는 엘라스틴(elastin)과 콜라겐(collagen)은 피부탄력에 가장 큰 영향을 준다. 진피 내 결합조직의 감소는 각질세포(keratinocyte)로부터 유리되는 콜라겐분해효소(collagenase), 젤라틴 분해효소(gelatinase) 등에 의한 것으로 알려져 있다. 엘라스틴 분해효소인 엘라스타아제(elastase)는 동물 결합 조직의 불용성 탄성섬유 단백질의 엘라스틴을 분해할 수 있는 유일한 효소이다. 엘라스타아제류의 단백질 분해효소는 단형핵 백혈구, 췌장, 혈소판, 단핵 백혈구, 대식세포, 평활근 세포 등에서 확인되었다. 백혈구 엘라스타아제는 세린 단백질 분해효소(serin proteinase)에 속하며, 섬유아세포 엘라스타제는 활성자리에 금속 이온을 포함하는 금속 단백질 분해효소(metalloproteinase,MP)에 속한다.As the skin ages, the epidermis, dermis, and subcutaneous are reduced, of which the most significant changes in dermis are the formation of wrinkles. The extracellular matrix in skin dermis plays the most important role in maintaining skin structure and elasticity. Elastin and collagen, which are present in the middle dermis, have the greatest effect on skin elasticity. give. The reduction of connective tissue in the dermis is known to be caused by collagenase, gelatinase, and the like that are released from keratinocytes. Elastase, an elastin degrading enzyme, is the only enzyme capable of breaking down the elastin of insoluble elastic fiber proteins in animal connective tissue. Elastase proteases have been identified in mononuclear leukocytes, pancreas, platelets, monocytes, macrophages, and smooth muscle cells. Leukocyte elastase belongs to serine proteinase, and fibroblast elastase belongs to metalloproteinase (MP) which contains metal ions in active sites.

피부는 선천적인 노화과정과 함께 자외선 노출로 인한 광노화에 의하여 심각한 손상을 입게 된다. 자외선은 UVA(320~400nm), UVB(290~320nm) 및 UVC (200~290nm)로 구별하는데, UVA는 UVB와 달리 진피층을 투과하여 광손상과 피부 노화를 촉진하는 것으로 알려져 있다. 피부 내로 흡수된 빛은 핵산, 아미노산 및 멜라닌 등 다양한 색소체들에게 빛에너지를 전달하게 되고, 그 결과, 색소체들은 광분해 반응을 일으켜 자유기들을 생성한다. 또한, 빛은 생체 내에 존재하는 유리 산소분자와 상호작용을 하여 수퍼옥사이드 이온 레디컬(superoxide anion radical)을 만들어 이들은 여러 가지 반응 경로를 거쳐 싱글 옥시겐(single oxygen, 1O2), 하이드록시 라디칼(hydroxyle radical, OH) 및 과산화수소(H2O2)와 같은 유해 활성산소 종을 만드는 연쇄반응을 거친다.The skin is severely damaged by the natural aging process and photoaging caused by UV exposure. UVA is distinguished by UVA (320-400nm), UVB (290-320nm) and UVC (200-290nm). Unlike UVB, UVA penetrates the dermis and is known to promote photo damage and skin aging. Light absorbed into the skin transmits light energy to various pigments such as nucleic acids, amino acids, and melanin. As a result, the pigments cause photolysis to generate free groups. In addition, light interacts with free oxygen molecules present in the living body to create superoxide anion radicals that pass through various reaction pathways to single oxygen ( 1 O 2 ) and hydroxy radicals. It undergoes a chain reaction to produce harmful free radical species such as (hydroxyle radical, OH) and hydrogen peroxide (H 2 O 2 ).

피부세포 및 조직손상을 주도하는 것은 이와 같은 유해 활성산소종이며, 이들은 항산화 효소와 비효소적 항산화제들로 구성된 항산화 방어망을 파괴하여, 결국에는 피부탄력 감소, 주름 및 기미, 주근깨 생성 등으로 피부노화가 가속화된다.It is these harmful reactive oxygen species that are responsible for skin cell and tissue damage, which destroys the antioxidant defenses made up of antioxidant enzymes and non-enzymatic antioxidants, resulting in reduced skin elasticity, wrinkles and blemishes, and freckles. Aging accelerates.

기능성 화장품 중, 미백제품은 자외선에 의한 멜라닌의 피부 색소 침착을 막아주는 기능을 가지고 있으며, 주름개선제품은 피부진피증의 콜라겐, 엘라스틴과 같은 물질들의 생성이나 진피세포의 증식 기능을 갖고 있다. 지금까지 알려져 있는 주름개선 성분에는 레티놀(retinol), 레티닐 팔미테이트(Retinyl palmitate), 아데노신(adenosine), 홍삼농축액, 토코페릴 아세테이트(tocopheryl acetate), 젖산, 태반 추출물 등이 있으며, 이들 중 가장 많이 사용되고 있는 레티놀은 열과 빛 공기에 쉽게 파괴되어 안정성이 떨어지며, 피부에 자극성이 있는 문제점이 있다.Among the functional cosmetics, whitening products have the function of preventing the skin pigmentation of melanin by ultraviolet rays, and wrinkle improvement products have the function of producing substances such as collagen and elastin of dermal dermatosis or proliferation of dermal cells. The anti-wrinkle ingredients known to date include retinol, retinyl palmitate, adenosine, red ginseng concentrate, tocopheryl acetate, lactic acid, and placenta extract. Retinol being used is easily destroyed by heat and light air, which is less stable and has a problem of irritating the skin.

오가피는 인삼과 같은 과인 오가피에 속해 있으며 우리나라의 전역과 중국의 동북부 지방, 러시아의 시베리아 및 일본 북해도에만 분포되어 있는데 국내에는 참오가피, 지리오가피, 섬오가피, 흰털오가피, 가시오가피 등 10여종의 오가피나무가 자생 및 재배되고 있다. 잎사귀의 모양이 인삼과 흡사할 뿐 아니라, 그 효능 면에서도 인삼 못지 않지 때문에 나무인삼 또는 나무산삼이라고 불려진다. 천식 관절염 등의 만성질환에 사용되어 온 오가피는 소염, 황산화, 콜레스테롤 저하, 면역 활성 및 항균 등의 효과도 보고되고 있다. Ogapi belongs to the same family of ginseng as the ginseng, and is distributed only throughout Korea, northeastern China, Siberia and Japan's Hokkaido in Korea. Are native and cultivated. Not only does the leaf look similar to ginseng, but also in terms of efficacy, it is called tree ginseng or wild ginseng. Ogapi, which has been used for chronic diseases such as asthma arthritis, has also been reported to have effects such as anti-inflammatory, sulfated, cholesterol lowering, immune activity and antibacterial activity.

오가피 자기방어능 회복으로 탄력있는 피부를 만들어준다고 알려져 있으나 과학적인 연구가 이루어지지 않고 있는 실정이다.Ogapi is known to make elastic skin by restoring self-defense ability, but scientific research has not been conducted.

따라서, 본 발명의 목적은 상기 종래기술의 문제점을 감안하여 안출한 것으로 흰털오가피 추출물을 이용하여 자외선에 의한 콜라겐과 엘라스틴 분해효소 억제 및 엘라스틴 생성 효과를 지닌 화장품 원료를 제공함에 있다.Accordingly, an object of the present invention is to provide a cosmetic raw material having an effect of inhibiting collagen and elastin degrading enzyme and elastin production by ultraviolet rays by using the white hairy opi extract in view of the problems of the prior art.

본 발명의 상기 목적은 잎, 줄기, 뿌리 등 흰털오가피(Acanthopanax divaricatus var . albeofructus)의 물 또는 에탄올 추출물을 시료로 사용하여 엘라스타아제 활성 저해도를 측정하고 이어서 인체 피부세포의 자외선 손상 정도를 측정한 후 엘라스틴 측정 및 피부에 대한 안전성을 확인하므로서 달성하였다.The object of the invention is a leaf, stem, root, etc. huinteol Acanthopanax measuring UV damage degree of the use of water or ethanol extract of the sample by measuring the elastase dehydratase activity inhibition, followed by human skin cells (Acanthopanax divaricatus var. Albeofructus) It was then achieved by measuring elastin and confirming safety for the skin.

본 발명은 잎, 줄기, 뿌리 등 흰털오가피(Acanthopanax divaricatus var . albeofructus)의 물 또는 에탄올 추출물을 시료로 사용하였다. 상기 잎, 줄기, 뿌리 등 흰털오가피의 물 또는 에탄올 추출물의 항산화활성를 측정하는 단계; 상기 흰털오가피의 부위별 물 또는 에탄올 추출물의 엘라스타아제 활성 저해도를 측정하는 단계; 상기 흰털오가피의 부위별 물 또는 추출물의 인체 피부세포의 자외선 손상 정도를 측정하는 단계; 상기 흰털오가피의 엘라스틴 측정 및 피부에 대한 안전성을 확인하는 단계로 구성된다.The present invention leaves, stems, roots, etc. Acanthopanax divaricatus var . albeofructus ) water or ethanol extract was used as a sample. Measuring the antioxidant activity of the water or ethanol extract of the white hairy organza such as leaves, stems, and roots; Measuring the degree of inhibition of elastase activity of water or ethanol extract for each part of the agar; Measuring the degree of UV damage of human skin cells of the water or extract of each part of the white hairy orange skin; It is composed of the step of measuring the elastin and the safety of the skin of the white hair organ.

이하, 본 발명의 구체적인 구성 및 작용을 바람직한 실시예와 실험예를 통하 여 상세히 설명한다.Hereinafter, the specific configuration and operation of the present invention will be described in detail through preferred embodiments and experimental examples.

실시예1Example 1 : : 흰털오가피White hair 추출물의 제조 Preparation of Extract

충남 천안시 소재 (주)수신오가피에서 재배한 흰털오가피(Acanthopanax divaricatus var . albeofructus)의 잎, 줄기, 뿌리를 구분하여 건조한 오가피의 열수추출물 분말을 시료로 사용하였다. 흰털오가피 분말을 멸균증류수에 용해시킨 용액을 흡수 크기가 다른 멤브레인 필터(membrane fileter)에 순차적으로 여과하여 (0.8, 0.45, 0.2um) 시용하였고, 또 흰털오가피 잎:줄기:뿌리를 1:5:4로 혼합한 혼합물의 물 추출물도 여과하여 사용하였다. 에탄올 추출물은 환류냉각기가 부착된 추출기에 건조한 오가피(잎, 줄기, 뿌리)와 95% 에탄올을 가하고 70℃ 수욕상에서 3시간 동안 가열하여 여과한 여액을 감압 농축하여 1:5:4로 혼합하여 동일하게 제조하였다.Cheonan Material Co., separated the leaves, stems, and roots of huinteol Acanthopanax (Acanthopanax divaricatus var. Albeofructus) grown in Acanthopanax receive a hot water extract powder was used as a sample of dried Acanthopanax. The solution obtained by dissolving the white hairy orange powder in sterile distilled water was sequentially applied (0.8, 0.45, 0.2um) to a membrane filter (membrane fileter) having a different absorption size, and the white hairy orange leaf: stem: root was 1: 5: The water extract of the mixture mixed with 4 was also used by filtration. Ethanol extract was added to dried extracts (leaves, stems, roots) and 95% ethanol in an extractor equipped with a reflux condenser, heated for 3 hours in a 70 ℃ water bath, and the filtrate was concentrated under reduced pressure and mixed at 1: 5: 4. To make.

실험예1: 흰털오가피의 항산화활성(1,1-diphenyl-2-picrylhydrazyl,; 이하 DPPH) 측정Experimental Example 1 Measurement of Antioxidant Activity (1,1-diphenyl-2-picrylhydrazyl, hereinafter DPPH)

상기 흰털오가피의 혼합물을 각 용액 100㎕에 0.1mM DPPH 용액(99.5% 에타놀에 용해) 1.9mL를 가하고, 혼합기(vortex mixer)로 10초간 진탕 후, 37℃에서 30분 동안 배양시킨 후 520nm에서 흡광도의 감소치를 측정하였다. 1.9 ml of 0.1 mM DPPH solution (dissolved in 99.5% ethanol) was added to 100 µl of each solution of the white hairy organza, shaken for 10 seconds with a vortex mixer, incubated at 37 ° C. for 30 minutes, and absorbance at 520 nm. The decrease of was measured.

상기 흰털오가피의 혼합물의 활성산소 소거작용(electron donating ability, EDA %)은 시료를 가하지 않은 대조군의 흡광도를 50%로 감소시키는데 필요한 시료 의 농도(IC50)로 나타내었다.The reactive oxygen scavenging ability (EDA%) of the mixture of the white hairy pulp was expressed as the concentration of the sample (IC 50 ) required to reduce the absorbance of the control group without the sample to 50%.

Figure 112006048942580-pat00001
Figure 112006048942580-pat00001

그 결과를 표 1에 나타내었다. 잎의 경우, IC50 = 12㎍/mL로 기존의 항산화제인 알파-토코페롤(α-tocopherol, IC50 = 12㎍/mL)과 대응할 정도의 우수한 항산화활성을 보였다. 또한, 잎, 줄기, 뿌리의 혼합추출물의 경우에도 우수한 활성을 보였으나 뿌리 및 줄기의 경우에는 항산화활성이 약간 떨어지는 것을 알 수 있었다. 그러나 에탄올 추출물의 경우에는 잎 추출물의 활성이 약간 낮은 반면, 줄기 추출물의 활성이 우수한 것으로 나타났다.The results are shown in Table 1. In the case of leaves, IC 50 = 12µg / mL showed excellent antioxidant activity corresponding to the conventional antioxidant alpha-tocopherol (α-tocopherol, IC 50 = 12µg / mL). In addition, the leaves, stems, mixed extracts of the roots showed excellent activity, but the roots and stems were found to be slightly lower in the antioxidant activity. In the case of ethanol extract, however, leaf extract activity was slightly lower, whereas stem extract activity was excellent.

표 1. 흰털오가피 추출물의 항산화활성도 (IC50) Table 1. Antioxidant Activity of White Hairy Oyster Extract (IC 50 )

물 추출물Water extract 에탄올 추출물Ethanol extract leaf 1212 4747 줄기stem 7070 3030 뿌리Root 5050 4747 혼합mix 2828 3333

* 혼합 = 잎:줄기:뿌리(1:5:4)* Blend = Leaf: Stem: Root (1: 5: 4)

실험예2: 흰털오가피 추출물의 엘라스타아제 활성 Experimental Example 2 Elastase Activity of the White Hairy Ogapi Extract

엘라스타아제 활성은 N-succinyl-L-Ala-Ala-p-nitroanilide를 기질로 하여 엘라스타아제에 의하여 기질로부터 분해된 산물 피-니트로아닐리드(p-nitroanilide)의 양을 측정하는데, 오가피 부위별 추출물과 기질을 섞은 후 25℃에서 20분간 미리 반응시킨 후, 엘라스타아제(20㎕/㎖)를 첨가하여 25℃에서 20분간 미리 반응시킨 후, 410nm에서 흡광도를 측정하였다. 엘라스타아제 활성의 1단위는 분당 1umol의 피-니트로아닐리드(p-nitroanilide)를 생성하는 활성으로 정의된다. 엘라스타아제 활성 저해율(%)은 다음의 식에 따라 계산하였다.Elastase activity measures the amount of product p-nitroanilide decomposed from the substrate by elastase using N-succinyl-L-Ala-Ala-p-nitroanilide as a substrate. After the mixture was mixed with the extract and reacted for 20 minutes at 25 ° C., an elastase (20 μl / ml) was added thereto, followed by reaction at 25 ° C. for 20 minutes, and the absorbance was measured at 410 nm. One unit of elastase activity is defined as the activity that produces 1 umol of p-nitroanilide per minute. Elastase activity inhibition rate (%) was calculated according to the following formula.

Figure 112006048942580-pat00002
Figure 112006048942580-pat00002

실험예3: 세포배양 및 세포주에 미치는 자외선의 영향Experimental Example 3: Effect of UV Light on Cell Culture and Cell Line

Modern Tissue Technology(대한민국)로부터 분양받은 인간 피부 섬유아세포(human dermal fibroblast;HDF-N)는 10% 소태아혈청(fetal bovine serum;FBS, GibcoBRL, Grand Island, USA), 1% 페니실린 스트립토마이신(penicillin streptomycin, GibcoBRL, Grand Island, USA), 배지에서 37℃(5% CO2/60% 상대습도)의 항온, 항습 배양기에서 배양하였다.Human dermal fibroblasts (HDF-N) received from Modern Tissue Technology (Korea) are 10% fetal bovine serum (FBS, GibcoBRL, Grand Island, USA), 1% penicillin striptomycin ( Penicillin streptomycin, GibcoBRL, Grand Island, USA) and cultured in a constant temperature, constant humidity incubator at 37 ℃ (5% CO 2 /60% relative humidity).

인간 피부 섬유아세포를 100mm 배양접시에 90%이상 배양한 후 96 웰 플레이트에 1X106 cells/mL로 분주한 다음 24시간 동안 배양하였다. 자외선 조사 직전에 PBS(phosphate buffered saline, Sigma, St Louis, Ml, USA)로 1회 세척하고, PBS를 세포가 살짝 잠길 정도로 넣어 준 상태에서 plate 뚜껑을 열고 자외선(UVA) 2~8 J/cm2을 조사한 즉시 다시 PBS로 1회 세척한 후 5% FBS를 첨가한 DMEM(Dulbecco's modified eagle medium)을 넣고 37℃, 5% CO2 배양기에서 배양 후 세포의 생존률을 MTT 측정으로 확인하였다.Human skin fibroblasts were cultured at 90% or more in a 100 mm culture dish, and then divided into 96 well plates at 1 × 10 6 cells / mL and incubated for 24 hours. Wash once with PBS (phosphate buffered saline, Sigma, St Louis, Ml, USA) just before UV irradiation, and open the plate lid with PBS slightly submerged. 2 ~ 8 J / cm Immediately after irradiating 2 , washed once with PBS again and then added DMEM (Dulbecco's modified eagle medium) added with 5% FBS at 37 ° C. and 5% CO 2. Cell viability after incubation in the incubator was confirmed by MTT measurement.

그 결과, 도 1 내지 2와 같이 조사된 자외선은 세포의 생존에 크게 영향을 미치지 않는 것으로 나타났으며 동일한 조건으로 자외선을 조사 후 생성되는 엘라스틴의 양을 측정한 결과 엘라스틴의 생성이 조사량에 의존적으로 감소하였다. 따라서 자외선 조사는 세포의 생존에는 영향을 미치지 않으나 세포 내에서 엘라스틴의 합성에는 영향을 미치는 것으로 볼 수 있다.As a result, the ultraviolet rays irradiated as shown in Figs. 1 and 2 did not significantly affect the survival of the cells, and as a result of measuring the amount of elastin generated after irradiation with ultraviolet rays under the same conditions, the production of elastin was dependent on the dose. Decreased. Thus, UV irradiation does not affect the survival of cells, but may affect the synthesis of elastin in the cells.

실험예4: 본 발명 흰털오가피 추출물의 피부세포 생존에 미치는 영향Experimental Example 4: Effect of White Hairy Ogai Extract of the Present Invention on Skin Cell Survival

본 발명 흰털오가피 추출물의 피부세포에 생존 효과를 확인하기 위하여 상기 흰털오가피의 물 또는 에탄올 추출물을 첨가한 세포를 48시간 동안 배양한 후, 인간 피부 섬유아세포를 1X105 cells/mL로 24 well plate에 500㎕씩 분주한 다음 24시간 배양하고, 배지의 10%를 제거한 후, 제거한 양만큼의 MTT(3-[4,5-dimerthylthiazol-2,5-diphenyltetrazolium bromide) 용액을 첨가하고, 4시간 동안 37℃, 5% CO2 배양기에서 배양하였다. 배양액을 제거한 후, DMSO(dimethysulfoxide, 덕산) 용액 300㎕씩을 첨가하고 혼합한 후, 세포의 생존률을 595nm에서 엘라이자(enzyme-linked immunosorbant assay;ELISA) 측정기(Molecular Device Co.)로 흡광도를 측정하였다. In order to confirm the survival effect on the skin cells of the white hairy oocyte extract, after culturing the cells added with the water or ethanol extract of the white hairy oocytes for 48 hours, human skin fibroblasts at 1X10 5 cells / mL in a 24 well plate Dispense 500 μl each and incubate for 24 hours, remove 10% of the medium, and then add as much MTT (3- [4,5-dimerthylthiazol-2,5-diphenyltetrazolium bromide) solution as much as removed, followed by 37 for 4 hours. C was incubated in a 5% CO 2 incubator. After removing the culture solution, 300 μl of DMSO (dimethysulfoxide, Duksan) solution was added and mixed, and the cell viability was measured at 595 nm using an enzyme-linked immunosorbant assay (ELISA) meter (Molecular Device Co.). .

실험 결과, 하기 표 2 내지 3에 나타낸 바와 같이, 오가피 잎, 줄기, 뿌리의 물 추출물은 10-5g/mL 이하의 농도에서 세포가 90% 이상 생존하는 것을 확인하였고, 에탄올 추출물은 10-4g/mL 이하의 농도에서 90% 이상 생존하는 것을 확인하였으며 본 발명 흰털오가피 물 또는 에탄올 추출물이 피부세포 생존에 거의 영향을 미치지 않는 것으로 판정되었다.As a result of the experiment, as shown in Tables 2 to 3, the water extracts of Ogapi leaves, stems, and roots were found to survive more than 90% of the cells at concentrations of 10 −5 g / mL and 10 −4 It was confirmed that more than 90% surviving at a concentration of g / mL or less, and it was determined that the present invention hair white pulp water or ethanol extract has little effect on skin cell survival.

표 2. 흰털오가피 물 추출물 처리 후 세포 생존율(%)Table 2. Cell survival rate (%) after treatment of albino water extract

농도a Concentration a 대조군b Control group b 10-13 10 -13 10-12 10 -12 10-10 10 -10 10-8 10 -8 10-6 10 -6 10-5 10 -5 leaf 100100 102±0.33102 ± 0.33 102±9.16102 ± 9.16 92±3.9892 ± 3.98 92±7.3692 ± 7.36 90±7.7190 ± 7.71 91±2.0291 ± 2.02 줄기stem 100100 104±5.54104 ± 5.54 99±3.3299 ± 3.32 93±2.1093 ± 2.10 90±0.6590 ± 0.65 90±0.7690 ± 0.76 90±1.9290 ± 1.92 뿌리Root 100100 100±5.22100 ± 5.22 95±1.0595 ± 1.05 94±8.7594 ± 8.75 92±7.0592 ± 7.05 90±6.7890 ± 6.78 90±4.3590 ± 4.35

농도a: 흰털오가피 물 추출물의 농도(g/mL)Concentration a : Concentration of albino water extract (g / mL)

대조군b: 흰털오가피 추출물이 처리되지 않은 세포Control group b : cells not treated with white hairy orange extract

표 3. 흰털오가피 에탄올 추출물 처리 후 세포 생존율(%)       Table 3. Cell survival rate (%) after treatment with ethanol extract

농도a Concentration a 대조군b Control group b 10-7 10 -7 10-6 10 -6 10-5 10 -5 10-4 10 -4 leaf 100100 95±0.0695 ± 0.06 95±1.3595 ± 1.35 95±0.1095 ± 0.10 90±9.4590 ± 9.45 줄기stem 100100 93±2.5093 ± 2.50 94±1.6594 ± 1.65 102±1.76102 ± 1.76 111±0.92111 ± 0.92 뿌리Root 100100 95±8.0595 ± 8.05 89±5.0589 ± 5.05 90±4.3890 ± 4.38 92±3.0592 ± 3.05

농도a: 흰털오가피 에탄올 추출물의 농도(g/mL)Concentration a : Concentration of ethanol extract of white hairy orange skin (g / mL)

대조군b: 흰털오가피 추출물이 처리되지 않은 세포Control group b : cells not treated with white hairy orange extract

실험예5: 흰털오가피 추출물의 엘라스틴 생성에 미치는 영향Experimental Example 5: Effect on the elastin production of white hairy ogapi extract

피부세포에서 엘라스틴 생성에 미치는 오가피 추출물의 영향을 알아보기 위하여 인간 피부 섬유아세포를 1X105 cells/mL로 24 웰 플레이트에 500㎕씩 분주한 다음 24시 동안 배양하였다. 흰털오가피 부위별 추출물을 포함하는 새로운 배지를 넣고 48시간 동안 37℃, 5% CO2 배양기에서 배양한 군과 PBS로 세척한 후 여러 광량으로 자외선을 조사하고 흰털오가피 부위별 추출물을 포함하는 새로운 배지를 넣고 48시간 동안37℃, 5% CO2 배양기에서 배양한 군으로 분류하여 상등액 100㎕를 취하였다. 엘라스틴 측정은 엘라스틴 측정 키트(elastin assay kit, Biocolor Ltd., UK)를 사용하여 405nm 흡광도에서 측정하였다.In order to examine the effect of the extract of oolong on elastin production in skin cells, 500 μl of human skin fibroblasts were dispensed in 24 well plates at 1 × 10 5 cells / mL and incubated for 24 hours. Add a new medium containing the extract of the white hairy skin parts and wash with PBS and the group incubated in 37 ℃, 5% CO 2 incubator for 48 hours, and irradiated with UV light in various light doses and a new medium containing extracts of the white hairy skin parts To this was placed for 48 hours at 37 ℃, incubated in a group cultured in a 5% CO 2 incubator 100μl of the supernatant was taken. Elastin measurements were measured at 405 nm absorbance using an elastin assay kit (Biocolor Ltd., UK).

실험 결과, 하기 표 4 내지 7와 같이, 세포에 흰털오가피 물 또는 에탄올 추출물을 처리한 경우 각각의 추출물이 엘라스틴 생성을 약간 감소 및 증가시키는 경향을 보였으나, 유의성이 없는 것으로 보아 흰털오가피 추출물이 엘라스틴 생성에 영향을 주지 않음을 알 수 있다. 피부세포에 엘라스틴의 생성을 80% 정도 억제시키는 자외선(6J/cm2)을 조사하고 흰털오가피 추출물 처리한 후, 자외선으로 인하여 손상된 세포의 엘라스틴의 합성능력이 어느 정도 회복되는 것으로 나타났다. 흰털오가피 물 추출물을 처리한 경우, 잎 추출물은 10-7g/mL(0.1㎍/mL) 농도에서 엘라스틴의 생성이 자외선을 처리하지 않은 대조군 이상(111±9.05%)으로 회복되었으며, 줄기 및 뿌리 추출물을 처리했을 때에도 각각 90 및 93%까지 회복되었다. 흰털오가피 에탄올 추출물을 처리한 경우에는 물 추출물의 경우보다 엘라스틴의 생성능력이 더욱 촉진되는 것을 알 수 있었다. 엘라스타아제 활성억제 실험에서는 비교적 높은 농도의 추출물이 엘라스타아제의 활성을 억제하였으나, 엘라스틴 생성촉진작용은 이보다 훨씬 낮은 농도에서 나타나는 것으로 보아 엘라스타아제 활성억제와는 관련이 없는 것으로 판단된다.As a result of the experiment, as shown in Tables 4 to 7, each of the extracts showed a tendency to slightly decrease and increase the production of elastin when the cells were treated with white hairy water or ethanol extract, but the white hairy orange extract was elastin. It can be seen that it does not affect the production. After irradiating the skin cells with ultraviolet light (6J / cm 2 ) that inhibits the production of elastin by about 80% and treating the white hairy orange extract, it was shown that the synthetic ability of elastin of the damaged cells due to the ultraviolet light was restored to some extent. When treated with albino water extract, the leaf extract recovered the elastin production at a concentration of 10-7 g / mL (0.1 µg / mL) to more than the control group (111 ± 9.05%) without UV treatment, and the stem and root extracts. The treatment also recovered to 90 and 93%, respectively. In the case of treatment with white hairy ethanol extract, it was found that the production ability of elastin was more promoted than that of water extract. In the elastase inhibitory experiments, relatively high concentrations of extracts inhibited the activity of elastase, but the elastin production-promoting action appeared at much lower concentrations, which is not related to the elastase inhibitory activity.

표 4. 피부세포에 흰털오가피 물 추출물 처리 후 엘라스틴 생성율(%)Table 4. Elastin production rate (%) after treatment with skin hair extract water on skin cells

농도a Concentration a 대조군b Control group b 10-9 10 -9 10-8 10 -8 10-7 10 -7 10-6 10 -6 10-5 10 -5 leaf 100100 94±5.6094 ± 5.60 96±4.9796 ± 4.97 95±4.3495 ± 4.34 101±16.89101 ± 16.89 95±6.8395 ± 6.83 줄기stem 100100 96±3.4496 ± 3.44 95±7.5495 ± 7.54 105±16.9105 ± 16.9 101±17.7101 ± 17.7 113±10.6113 ± 10.6 뿌리Root 100100 95±8.2495 ± 8.24 98±9.9398 ± 9.93 93±10.8793 ± 10.87 101±3.42101 ± 3.42 103±6.33103 ± 6.33

농도a: 흰털오가피 에탄올 추출물의 농도(g/mL)Concentration a : Concentration of ethanol extract of white hairy orange skin (g / mL)

대조군b: 흰털오가피 추출물이 처리되지 않은 세포Control group b : cells not treated with white hairy orange extract

표 5. 피부세포에 흰털오가피 에탄올 추출물 처리 후 엘라스틴 생성율(%)Table 5. Elastin production rate (%) after treatment with skin hair ethanol extract on skin cells

농도a Concentration a 대조군b Control group b 10-8 10 -8 10-7 10 -7 10-6 10 -6 10-5 10 -5 10-4 10 -4 leaf 100100 93±4.4093 ± 4.40 101±3.57101 ± 3.57 107±3.77107 ± 3.77 108±3.81108 ± 3.81 106±3.76106 ± 3.76 줄기stem 100100 97±9.4097 ± 9.40 98±2.8798 ± 2.87 102±0.47102 ± 0.47 90±7.2490 ± 7.24 103±12.8103 ± 12.8 뿌리Root 100100 105±4.46105 ± 4.46 99±9.6099 ± 9.60 105±1.47105 ± 1.47 101±9.51101 ± 9.51 107±4.35107 ± 4.35

농도a: 흰털오가피 에탄올 추출물의 농도(g/mL)Concentration a : Concentration of ethanol extract of white hairy orange skin (g / mL)

대조군b: 흰털오가피 추출물이 처리되지 않은 세포Control group b : cells not treated with white hairy orange extract

표 6. 자외선 처리된 피부세포에 흰털오가피 물 추출물 처리 후 엘라스틴 생성율(%)Table 6. Elastin production rate after treatment with white hairy orange water extract on UV-treated skin cells

농도a Concentration a 대조군b Control group b UVAc UVA c 10-9 10 -9 10-8 10 -8 10-7 10 -7 10-6 10 -6 10-5 10 -5 leaf 100100 80±1.1380 ± 1.13 88±8.8688 ± 8.86 90±7.1490 ± 7.14 111±9.05111 ± 9.05 98±9.7998 ± 9.79 92±14.3292 ± 14.32 줄기stem 100100 80±1.1380 ± 1.13 83±9.3083 ± 9.30 83±8.5983 ± 8.59 90±1.4290 ± 1.42 86±9.8786 ± 9.87 85±9.4285 ± 9.42 뿌리Root 100100 80±1.1380 ± 1.13 89±5.7889 ± 5.78 91±6.8491 ± 6.84 93±5.6793 ± 5.67 93±8.9493 ± 8.94 91±8.3091 ± 8.30

농도a: 흰털오가피 에탄올 추출물의 농도(g/mL)Concentration a : Concentration of ethanol extract of white hairy orange skin (g / mL)

대조군b: 흰털오가피 추출물이 처리되지 않은 세포Control group b : cells not treated with white hairy orange extract

UVAc: UVA(6J/cm2) 처리된 피부세포에서 생성된 엘라스틴UVA c : Elastin produced from UVA (6J / cm 2 ) treated skin cells

표 7.자외선 처리된 피부세포에 흰털오가피 에탄올 추출물 처리 후 엘라스틴 생성율(%)Table 7.Elastin production rate after treatment with ethanol extract of white hairy orange skin on UV-treated skin cells

농도a Concentration a 대조군b Control group b UVAc UVA c 10-7 10 -7 10-6 10 -6 10-5 10 -5 10-4 10 -4 leaf 100100 80±12.6580 ± 12.65 91±10.6591 ± 10.65 102±4.51102 ± 4.51 94±10.6094 ± 10.60 98±12.1198 ± 12.11 줄기stem 100100 80±12.6580 ± 12.65 101±33.7101 ± 33.7 96±20.9796 ± 20.97 101±18.5101 ± 18.5 103±6.08103 ± 6.08 뿌리Root 100100 80±12.6580 ± 12.65 89±7.5189 ± 7.51 91±13.2191 ± 13.21 99±6.3499 ± 6.34 96±6.7496 ± 6.74

농도a: 흰털오가피 에탄올 추출물의 농도(g/mL)Concentration a : Concentration of ethanol extract of white hairy orange skin (g / mL)

대조군b: 흰털오가피 추출물이 처리되지 않은 세포Control group b : cells not treated with white hairy orange extract

UVAc: UVA(6J/cm2) 처리된 피부세포에서 생성된 엘라스틴UVA c : Elastin produced from UVA (6J / cm 2 ) treated skin cells

실험예6: 피부에 대한 흰털오가피 추출물의 안전성 검사Experimental Example 6: Safety test of white hairy orange extract on skin

본 발명의 흰털오가피 추출물에 대한 인체 피부에 안전성 검사를 하기 위하여 20세 이상 40세 미만의 건강한 성인 남녀 10명을 피험자로 선정하여 추출물을 팔의 안쪽에 도포하였다. 48시간 경과 후 탈지면으로 추출물을 제거하고, 상태를 판독한 후, 다시 48시간을 경과 후 피부의 상태를 판독하였다. 판정기준은 아래의 표 8과 같으며, 판독결과의 피부 반응도를 아래의 식에 따라 계산하였다. 또한 피부 반응도를 미리 정한 다음의 표 9의 판정기준에 준거하여 각 시료의 반응도를 판정하였다.In order to perform a safety test on the human skin of the white hairy orange extract of the present invention, ten healthy men and women under 20 years of age were selected as a test subject, and the extract was applied to the inside of the arm. After 48 hours, the extract was removed with cotton wool, the condition was read, and after 48 hours, the skin condition was read. Judging criteria are shown in Table 8 below, and the skin reactivity of the readings was calculated according to the following equation. In addition, the reactivity of each sample was determined based on the criteria of Table 9 below, in which the skin reactivity was determined in advance.

Figure 112006048942580-pat00003
Figure 112006048942580-pat00003

표 8. 인체 반응 등급Table 8. Human Response Ratings

반응reaction 등급Rating 판단judgment -- 00 무반응(No response)No response ±± 0.50.5 불확실(Doubtful response)Doubtful response ++ 1One 약한반응(Weak reaction)Weak reaction ++++ 22 조금 강한 반응(Strong reaction)Strong reaction ++++++ 33 매우 강한 반응(Very strong reaction)Very strong reaction

표 9. 피부 반응의 판정 기준Table 9. Criteria for Determination of Skin Response

평균 반응Average response 평가evaluation 0.0 ~ 0.90.0 to 0.9 자국이 없음No marks 1.0 ~ 2.91.0 to 2.9 약간의 자극이 있음Slight irritation 3.0 ~ 4.93.0 to 4.9 자극이 있음 I have a stimulus > 5.0> 5.0 매우 자국이 심함Very scary

실험결과, 표 8의 기준에 따라 흰털오가피의 잎, 줄기, 뿌리 추출물 모두 전체 피험자에서 반응이 없는 것으로 나타났으며, 표 9의 피부 반응도 판정 기준에 의하여 자극이 없는 것으로 판명되었다.As a result, all of the leaves, stems, and root extracts of the white hairy cucumber skin showed no response in all the subjects according to the criteria of Table 8, and it was found that there was no irritation by the skin reactivity criteria of Table 9.

상기 실험결과들은 평균±표준편자로 표기하였고, 통계적 유의성은 스튜던츠(student's) t-test로 하였으며 p값이 0.05미만일 때 통계적으로 유의하다고 판단하였다.The experimental results were expressed as mean ± standard deviation, and statistical significance was determined by Student's t-test and judged to be statistically significant when p value was less than 0.05.

이상 실시예 및 실험예를 통하여 설명한 바와 같이, 흰털오가피 부위별 추출물들은 항산화활성이 크고 엘라스타아제 활성을 억제하는 효과가 있으므로 흰털오 가피 추출물은 피부 탄력성의 복구 효과가 있다.As described through the above Examples and Experimental Examples, the extracts of the white hairy skin parts have a high antioxidant activity and have an effect of inhibiting the elastase activity, so the white hairy skin extract has a restorative effect on skin elasticity.

본 발명 흰털오가피 추출물은 피부 탄력을 유지하는 엘라스틴이 태아 발달 과정 초기에 많이 생성되는 반면, 어른이 되면 그 생성이 현저히 감소하는 특성으로 볼 때 엘라스타아제 활성 억제효과와 엘라스틴의 생성을 증가시키므로 피부 탄력 증가에 탁월한 효과가 있다. In the present invention, the white hair organ extract extracts a lot of elastin that maintains skin elasticity in the early stages of fetal development, whereas in adulthood its production is markedly reduced, which increases the effect of inhibiting elastase activity and the production of elastin. It has an excellent effect on increasing elasticity.

이 밖에도, 흰털오가피 추출물은 피부와 오랜 시간 접촉하는 화장품의 소재로서 사람 진피 세포주에 적용하였을 때 세포 독성이 전혀 나타나지 않았고 인체 실험을 통하여 피부에 자극이 거의 없음이 확인되었으므로 피부주름개선 기능을 가진 안전성이 높은 화장품 소재로 적용할 수 있는 효과가 있으므로 화장품 산업상 매우 유용한 발명인 것이다.In addition, the white hairy orange extract is a material of cosmetics that has been in contact with the skin for a long time. When applied to human dermal cell lines, no cytotoxicity was observed, and it was confirmed that there is little irritation to the skin through human experiments. This is a very useful invention in the cosmetic industry because it has an effect that can be applied to high cosmetic materials.

Claims (3)

흰털오가피(Acanthopanax divaricatus var. albeofructus) 잎의 물 추출물 또는 흰털오가피 줄기의 에탄올 추출물을 함유함을 특징으로 하는 자외선에 의한 인체 피부주름 방지용 화장품 조성물. Acanthopanax divaricatus var. Albeofructus ( Acanthopanax divaricatus var. Albeofructus ) A cosmetic composition for preventing human skin wrinkles caused by ultraviolet rays, characterized in that it contains water extracts or ethanol extracts of stems. 삭제delete 제 1항에 있어서, 상기 화장품 조성물의 제형이 유연화장수, 수렴화장수, 영양화장수, 영양크림, 맛사지크림, 에센스, 겔, 팩, 파우더, 피부외용연고, 첩보제, 현탁액, 에멀젼, 스프레이 또는 미용액인 것을 특징으로 하는 자외선에 의한 인체 피부주름 방지용 화장품 조성물.The method of claim 1, wherein the formulation of the cosmetic composition is a softening cosmetics, astringent cosmetics, nourishing cosmetics, nutrition cream, massage cream, essences, gels, packs, powders, external skin ointments, eye patch, suspension, emulsion, spray or cosmetic Cosmetic composition for preventing human skin wrinkles by ultraviolet rays, characterized in that.
KR1020060064092A 2006-07-07 2006-07-07 A cosmetic composition for preventing human skin wrinkle by ultraviolet radiation KR100813297B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020060064092A KR100813297B1 (en) 2006-07-07 2006-07-07 A cosmetic composition for preventing human skin wrinkle by ultraviolet radiation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020060064092A KR100813297B1 (en) 2006-07-07 2006-07-07 A cosmetic composition for preventing human skin wrinkle by ultraviolet radiation

Publications (2)

Publication Number Publication Date
KR20080005019A KR20080005019A (en) 2008-01-10
KR100813297B1 true KR100813297B1 (en) 2008-03-13

Family

ID=39215583

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020060064092A KR100813297B1 (en) 2006-07-07 2006-07-07 A cosmetic composition for preventing human skin wrinkle by ultraviolet radiation

Country Status (1)

Country Link
KR (1) KR100813297B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101207837B1 (en) 2009-01-14 2012-12-04 한국원자력연구원 Preparation method for extract of Suaeda japonica improved antioxidation property by irradiation and the extract

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005171003A (en) * 2003-12-09 2005-06-30 Fancl Corp Antioxidant
JP2006022094A (en) * 2004-06-10 2006-01-26 Fancl Corp NEW 3,4-seco-LUPANE TYPE TRITERPENOID SAPONIN COMPOUND

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005171003A (en) * 2003-12-09 2005-06-30 Fancl Corp Antioxidant
JP2006022094A (en) * 2004-06-10 2006-01-26 Fancl Corp NEW 3,4-seco-LUPANE TYPE TRITERPENOID SAPONIN COMPOUND

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101207837B1 (en) 2009-01-14 2012-12-04 한국원자력연구원 Preparation method for extract of Suaeda japonica improved antioxidation property by irradiation and the extract

Also Published As

Publication number Publication date
KR20080005019A (en) 2008-01-10

Similar Documents

Publication Publication Date Title
KR101081914B1 (en) Skin-care agent containing oriental-herb extracts
KR101035858B1 (en) Sargassum sp. extract that have low photo-induced cytotoxicity, preparation method thereof and cosmetic composition containing the same
KR20080001791A (en) Skin anti-wrinkle cosmetics composition containing forsythiae fruit extract
KR101617152B1 (en) A cosmetic composition containing extracts from immature fruits of Rhus javanica Linne
TW200948392A (en) Herbal composition for skin care
KR20070002409A (en) Cosmetic composition containing as available ingredient the extracts of Equisetum arvense L.
KR101853743B1 (en) External composition for skin containing Kalopanax pictus (Thunb.) Nakai extract
KR101135444B1 (en) Cosmetic composition for improvement of the skin wrinkles containing Palmitoyl Oligo peptide and Eucommia ulmoides extract
KR20110023435A (en) Composition containing glycoproteins extract from plant
KR101639578B1 (en) Cosmetic composition containing Ocimum basilicum seed extract
KR20120025244A (en) Cosmetic compositions for improving skin wrinkles comprising extract of camellia sasanqua
KR100813297B1 (en) A cosmetic composition for preventing human skin wrinkle by ultraviolet radiation
Kang et al. Antiphotoaging potential of extracts of yin-tonic herbal medicine in skin cell and human skin equivalent
KR20160096272A (en) A skin-care agent containing Mesembryanthemum crystallinum L. fermentation extract using yeast
KR101208013B1 (en) A skin-care agent containing mycoleptodonoides aitchisonii mycelium extract
KR20070109426A (en) A cosmetic composition containing an extract of typhae pollen
KR100563547B1 (en) A cosmetic composition containing extract of Lespedeza bicolor turczaninow var and/or Solanum nigrum L
Kim et al. Anti-wrinkle effect of Ulmus davidiana extracts
KR101810825B1 (en) Cosmetics compositions containing fermentation extract from leaf Daphniphyllum macropodum Miq.
KR101155512B1 (en) A skin protective composition from Ecklonia stolonifera
KR20130062045A (en) Skin external composition containing asplenium scolopendrium l. extract
KR20090097232A (en) Cosmetic compositions containing extract of viburnum dilatatum thunb used for antiwrinkle
KR100967805B1 (en) cosmetic compositions containing extract of Ostrya japonica Sarg used for antiwrinkle
KR20230109833A (en) Composition for improving skin condition with anti-wrinkle, anti-oxidant and moisturizing of UVB-damaged skin from extract of Citrus junos seed shell as active ingredient
KR20020090545A (en) Anti-aging cosmetics composition containing phenolic compound

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
G170 Re-publication after modification of scope of protection [patent]
LAPS Lapse due to unpaid annual fee